Group 1: Investor Relations Activities - The investor relations activity was a targeted research event held on January 21, 2026, from 10:00 to 11:00 in Benxi City [2][3] - Participants included representatives from various asset management firms and funds, such as Taibao Asset and Morgan Stanley Huaxin [3] Group 2: Major Asset Restructuring - The company disclosed a major asset restructuring plan in June 2023, which may significantly increase reliance on controlling shareholders and affect independent operations [4] - The feasibility and compliance of the restructuring plan are under further scrutiny, with ongoing evaluations and necessary disclosures to be made [4] Group 3: Convertible Bond Management - The company is preparing for the maturity of its convertible bonds by enhancing market value management and exploring financing channels [4] - Strategies include cost reduction, efficiency improvements, and professional integration to enhance profitability [4] Group 4: Industry Competition and Strategy - Following the restructuring of the controlling shareholder, there is a recognition of overlapping competition with Angang Group, which will be addressed through asset restructuring and business adjustments [4] - The company aims to respond to industry trends and optimize production while adhering to market demands [4] Group 5: Financial Performance and Future Goals - The company has faced three consecutive years of losses, with measures in place to comply with Shenzhen Stock Exchange regulations to avoid being classified as ST [4] - The target for automotive steel sales in 2026 is to focus on high-end products, aiming for significant growth and positioning as a core supplier to mid-to-high-end customers [4][5]

Group 1: Production Capacity and Operations - The current production capacity of spandex is 100,000 tons [2] - The production capacity of aramid fiber is 32,000 tons [3] - The company plans to increase the load in 2026 [3] - The inventory level is approximately 1 to 2 months [3] - The production in Yantai is specialized, yielding a slight premium despite higher costs [3] Group 2: Market Demand and Pricing - The market share of foreign products in the domestic market is currently low [3] - The expected export volume of aramid fiber in 2025 is around 20% [3] - The growth in market demand for aramid fiber is estimated to be in single digits, lower than spandex [3] - The competitive pressure in the aramid fiber market is significant, with increased production capacity leading to lower prices [5] Group 3: Product Development and Innovations - The company is exploring applications in smart fibers, including luminous clothing and automotive interiors [4] - There is ongoing research into new engineering technologies for aramid fiber [5] - The company is working on green dyeing processes, although achieving the original goals has proven challenging [4] Group 4: Financial Performance and Strategy - The export segment has a higher gross margin, primarily driven by aramid fiber [5] - The company is considering investments in chlorinated compounds and has multiple suppliers for raw materials [5][7] - The company’s financial indicators may diversify beyond traditional metrics to include revenue and market valuation [6]

Group 1: Overseas Market Performance - In the first half of 2025, the company's overseas market revenue reached 327 million yuan, representing a year-on-year growth of 34% [2] - The European and Middle Eastern markets showed particularly significant growth, with a differentiated strategy implemented for various regions to meet customer needs [2][3] - The company has adopted a systematic coverage strategy for different market maturities, focusing on expanding value customer coverage in mature markets and enhancing channel empowerment in emerging markets [2][3] Group 2: Sales Model and Export Policies - The company employs a combination of distribution and direct sales models in overseas markets, with direct sales primarily targeting large dental laboratories [3] - Currently, there is no indication that the rare earth export control policies have affected the pricing of zirconia blocks used in all-ceramic dental products, although potential cost pressures may arise for overseas companies [3] - The company's export business has not been impacted by the rare earth export control policies to date [3] Group 3: Shareholder Actions - The company disclosed a plan for major shareholders to reduce their holdings, with a maximum reduction of 3,196,930 shares (3.0000% of total share capital) within three months following the announcement [3][4] - As of now, no other shareholders holding more than 5% have announced similar reduction plans, and any future developments will be disclosed in accordance with regulatory requirements [3][4]

Business Overview - Lizhu Biopharmaceuticals operates three main business segments: autoimmune, reproductive, and vaccine fields [2][3] - The core product in the autoimmune field, Lakanqita monoclonal antibody, has shown superior efficacy in clinical trials compared to competitors [4][5] Autoimmune Field - Lakanqita monoclonal antibody targets IL-17A/F dual sites, with a PASI100 response rate of 49.5% in clinical trials, outperforming the control group at 40.2% [4] - The product is expected to receive approval by the end of 2026, with significant market potential due to its unique characteristics [5] Reproductive Field - The recombinant human follicle-stimulating hormone (r-FSH) injection is anticipated to be approved within the year, reinforcing the company's leadership in assisted reproduction [3] Vaccine Field - The quadrivalent recombinant protein influenza vaccine is the first of its kind with an adjuvant, having completed Phase I trials and expected to enter Phase II in March [3] International Expansion Strategy - The company adopts a dual-track strategy for international expansion, focusing on licensing out innovative pipelines and direct exports to emerging markets [5][6] - Key markets include Southeast Asia and South America, with Vietnam and Brazil as strategic hubs for regulatory advantages and market growth [6] Cardiovascular Pipeline - H001, an oral direct thrombin inhibitor, is the fastest progressing project in its category, aimed at preventing venous thromboembolism (VTE) post-orthopedic surgeries [7] - The product has shown comparable efficacy to standard therapies and is preparing for Phase III trials [8] GnRH Pipeline - The GnRH pipeline covers all related indications and various formulations, making it the most comprehensive in China [9] - Key products include leuprolide with multiple formulations expected to launch soon, enhancing market presence [9] Chemical Preparation Segment - The chemical preparation segment generated revenue of 4.72 billion CNY, accounting for 51.8% of the company's total revenue in the first nine months of 2025 [10][11] - Growth drivers include product upgrades, innovation, and a focus on core therapeutic areas [11][12]

Group 1: R&D Investment and Innovation - The company has prioritized R&D innovation since its establishment, with over 20 years of continuous investment in time and talent, and plans to further increase R&D investment focusing on three main areas: talent acquisition, advanced laboratory setup, and collaboration with academic institutions [2][3] - The company aims to build a professional R&D talent matrix by attracting high-end talent and experts in materials science, protective technology, and coating technology [2] - The establishment of advanced laboratories and testing platforms is intended to enhance the full-process R&D infrastructure [2] Group 2: Competitive Advantages of Nano Fluid Materials - The core technological advantages include a unique shear-thickening effect that provides flexible protection with intelligent dynamic response capabilities, surpassing traditional hard materials in key protective indicators [3] - The product structure achieves a balance between lightweight and high performance, reducing weight by over 40% while meeting national standards for puncture resistance [3] - The company has achieved self-research and mass production of key raw materials, significantly lowering costs and ensuring strategic autonomy [3] Group 3: Market Growth and Channel Strategy - In the first three quarters of 2025, the company's security product revenue experienced nearly 100% year-on-year growth [3] - The channel strategy covers both C-end and B-end markets, utilizing mainstream e-commerce platforms to reach end consumers while also focusing on professional markets [3] - The security materials can be combined with fabrics to enhance wear-resistant and puncture-resistant performance, with applications in military, police, and high-end protective gear [3] Group 4: B-end Transformation and Future Planning - The company is building B-end transformation capabilities by forming a dedicated B-end market team and integrating upstream and downstream resources [4] - The current revenue structure is primarily C-end, providing stable cash flow, while future plans include a dual development strategy for C/B-end markets to ensure high-quality growth [4] - The company has sufficient production capacity to meet current demand across various channels, with plans for flexible capacity expansion based on market growth [4]

Group 1: Company Overview and Shareholder Actions - The actual controller and concerted actors disclosed a share reduction plan on September 10, 2025, and completed the reduction on January 6, 2026, maintaining a 51.71% shareholding post-reduction, ensuring absolute control [1] - The share reduction was primarily due to personal funding needs and is considered a normal market behavior, which may help optimize the company's equity structure in the long run [1] - The company is currently in the early stages of a specific object stock issuance plan, aimed at financing the industrialization of liquid cooling systems and expansion of semiconductor packaging materials [2] Group 2: Market Position and Competitive Landscape - The domestic liquid cooling market includes system integrators and core component manufacturers, evolving from project-based delivery to standardized products and platform capabilities [3] - The company adopts a differentiated strategy in the liquid cooling business, targeting both domestic and overseas markets, with a focus on core components for international clients and system-level solutions for domestic customers [3] - The industry has high barriers to entry, including long customer validation cycles and stringent supply chain collaboration requirements [3] Group 3: Financial Performance and Profitability - The current gross margin for the liquid cooling business is constrained by initial production scale and does not reflect the potential for profitability at scale [5] - The company anticipates that as order volumes increase, gross margins will significantly improve due to lower manufacturing costs and higher production efficiency [6] Group 4: Business Development and Future Plans - The company has transitioned from smart card business to the liquid cooling sector, leveraging its expertise in semiconductor packaging materials and establishing a professional team for development and customer service [7] - Current funding for new projects is based on careful planning to support R&D and capacity building, with initial capacity meeting early order demands [7] - The company aims to enhance its traditional smart card business while focusing R&D resources on semiconductor packaging and liquid cooling [8] Group 5: Risk Management and Market Outlook - Rising raw material prices, including copper, gold, and silver, pose cost pressures, but the company has established price linkage mechanisms with clients to mitigate these impacts [9] - The liquid cooling market is expected to grow rapidly, becoming a significant revenue source as customer mass production is introduced [10] - The company has entered the overseas supply chain through partnerships and is actively expanding its market presence [11] Group 6: Investment Appeal and Future Valuation - The current high price-to-earnings ratio reflects historical revenue from the smart card business and does not fully capture the growth potential of the liquid cooling and semiconductor packaging sectors [15] - The upcoming capital increase aims to enhance key capabilities and production capacity, improve customer onboarding efficiency, and optimize the business structure for long-term stability [16] - The company acknowledges potential risks in new product development and market validation, emphasizing the importance of rational investment and risk awareness for investors [16]

编号：2026-01 证券代码：002520 证券简称：日发精机 浙江日发精密机械股份有限公司 投资者关系活动记录表 投资者关系 活动类别 □特定对象调研 □分析师会议 □媒体采访 □业绩说明会 □新闻发布会 ☑路演活动 □现场参观 □其他 参与单位 名称 1、华创证券有限责任：范益民、丁祎、陈宏洋 2、太平资产管理有限公司：朱云、赵洋 3、中金资产管理有限公司：韩诚 4、浦银安盛基金管理有限公司：邹江渝 5、上海瀛赐私募基金管理有限公司：胡小骏 6、诺德基金管理有限公司：牛致远 7、路博迈基金管理（中国）有限公司：范适 8、国投瑞银基金管理有限公司：李耀徽 9、天风证券股份有限公司上海证券自营分公司权益投资部：杜玙 10、上海康橙投资管理股份有限公司：谭飞 11、上海浦东科技创业投资有限公司：王佳璇 12、上海大筝资产管理有限公司：宋博雅 13、北京中成博泰投资管理有限公司：卢慧 14、上海贝寅私募基金管理有限公司：杨兆媛 | | 15、中财招商投资集团商业保理有限公司：周康 | | --- | --- | | | 16、上海厚港私募基金管理有限公司：刘冠 | | | 17、厦门中略投资管理有限公司：姚迪 ...

Group 1: Financial Performance - In the first three quarters of 2025, the company reported a revenue of 2.265 billion yuan, a year-on-year decrease of 20.70% [2] - The net profit for the same period was 392 million yuan, reflecting a year-on-year decline of 45.69% [2] - Basic earnings per share stood at 0.7327 yuan, also down by 45.69% compared to the previous year [2] - The weighted average return on net assets was 9.16%, a decrease of 9.20% year-on-year [2] Group 2: Product Overview - The company's main business focuses on two core segments: compressors and vacuum pumps, with compressors further divided into refrigeration and air compression series [2] - The refrigeration product matrix includes commercial central air conditioning compressors, refrigeration compressors, and heat pump compressors, catering to diverse cooling and temperature control needs [2] - The air compressor products are essential in various industries, including engineering machinery, pharmaceuticals, chemicals, electronics, and road maintenance, ensuring efficient production processes [3] Group 3: Market Position and Competition - The main competitor for the magnetic suspension compressor is Danfoss [2] - The company is actively expanding into the oil-free air compressor market, targeting industries with high air quality requirements, such as food, biomedicine, and electronics [3] - The semiconductor vacuum pump faces competition from Edwards [3] - Sales revenue for vacuum products decreased in 2025, primarily due to a decline in the photovoltaic industry, but the impact is expected to lessen as the proportion of vacuum pumps used in photovoltaics decreases [3]

Group 1: Company Overview - Taihe New Materials Group Co., Ltd. operates through four main divisions: Advanced Textiles, Security and Information, New Energy Materials, and Chemical Division [2][3] - The Advanced Textiles Division focuses on spandex and smart fibers, with spandex characterized by high elongation and rebound [2] - The Security and Information Division primarily deals with aramid fibers, which have properties such as flame resistance and high strength [2] Group 2: Production and Capacity - Spandex production capacity is currently at 100,000 tons [3] - The company has seen improvements in spandex operating rates, contributing to reduced losses [3] - The goal for most products is a double-digit growth in production by 2026 [5] Group 3: Market and Pricing - Approximately 20% of aramid fiber is exported, with better profitability in international markets compared to domestic [3] - The global demand for aramid paper in aerospace applications is significant, with an estimated usage of 4,000 to 5,000 tons [3][4] - The pricing of aramid products varies by region and application, with higher prices observed in overseas markets [3] Group 4: Future Plans and Challenges - The company plans to build technical platforms for future chemical products once existing capacities are optimized [5] - There is a focus on engineering technology improvements to enhance product quality and reduce costs [3] - The self-sufficiency rate for aramid raw materials is approximately 40-50% [5]

Group 1: Financial Performance - The company expects a net profit attributable to shareholders for 2025 to be between 5,700 and 7,000 million yuan, representing a year-on-year growth of 56% to 91% [2] - The company anticipates improved profitability following the peak of fixed asset depreciation [4] Group 2: Product Development and Market Expansion - The company is expanding its LCP (Liquid Crystal Polymer) production capacity with a new 20,000-ton project in Chongqing, enhancing its market presence in high-frequency communications and AI computing sectors [3] - The company has successfully completed the acceptance of a central budget LCP film project, which will promote the industrialization of LCP films in high-end electronic devices [3] - The company has diversified its product offerings beyond LCP to include specialty nylon, PPS, PTFE, and PEEK, with ongoing growth in shipments for these materials [4] Group 3: Strategic Acquisitions and Market Position - The company formed negative goodwill in 2025 due to the acquisition of Shanghai Water Huaben Sealing Products Co., Ltd. at a price below its assessed value, positively impacting profits [5] - The company aims to become a comprehensive provider of semiconductor component solutions, significantly accelerating the localization process in the semiconductor materials sector [5] Group 4: Future Outlook and Competitive Advantage - The company plans to maintain its leading position in the specialty materials industry through continuous R&D investment and capacity expansion [5] - The focus will be on building differentiated competitive advantages and expanding market share in the context of domestic technology independence and high-end manufacturing upgrades [5]